Thymogam 250mg Injection

Thymogram 250mg Injection contains Antithymocyte Immunoglobulins as its active ingredient. This injection is a purified and sterile version of gamma globulin, derived from the hyperimmune plasma of horses that have been immunized with components of human white blood cells. It is utilized following kidney transplants and other therapies to manage and postpone organ rejection. After a solid organ transplant, the body mounts a vigorous immune response, identifying the antigens of the transplanted organ as foreign. Therefore, the administration of immunosuppressive agents is essential post-transplant to avert organ rejection.

Aplastic anemia is a disorder marked by the bone marrow’s inability to produce an adequate number of blood cells. Thymogram 250mg Injections are employed to treat severe aplastic anemia, suppress the immune system, and mitigate the immune-mediated destruction of bone marrow cells. This treatment aids in restoring normal blood cell production. Additionally, Thymogram 250mg Injection can reduce the necessity for high doses and extended use of corticosteroids in immunosuppressive therapies, thereby minimizing potential side effects and risks. Patients with known hypersensitivity or a history of severe allergic reactions to Thymogram 250mg Injection or any of its components should refrain from using it. Live vaccines are generally advised against during treatment. Patients with active infections, especially severe or systemic ones, should only receive the injection once the infection has been adequately treated and resolved.